Elevated Neutrophil to Lymphocyte Ratio Predicts Poor Prognosis in Advanced Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy
Oncology, 04/26/2012
Clinical Article
Kaneko M et al. – Elevated neutrophil to lymphocyte ratio (NLR) is a powerful predictor of poor response to oxaliplatin–based chemotherapy in patients with unresectable colorectal cancer (CRC). The ratio is a simply accessible and inexpensive but useful biomarker in CRC patients receiving chemotherapy.



